EichorEICHOR
Study identifier: NCT07696403 Synced from ClinicalTrials.gov · August 02, 2026
● Not Yet Recruiting

Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose

Condition: Nutrition, Healthy · Dyslipidemia · Overweight and Obesity  ·  Sponsor: University of Georgia

PhaseNA
Planned participants90
Who can joinAll sexes, 25 Years to 75 Years
Healthy volunteersYes

About this study

Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. The bioactive compounds contained in tree nuts have been shown to beneficially affect cardiometabolic health outcomes. Pecans contain more total phenols, sterols, and flavonoids than any other tree nut. They also are a rich source of polyunsaturated fatty acids (PUFAs), fiber, vitamin A, vitamin E, folic acid, calcium, magnesium, phosphorus, potassium, and zinc. These bioactive components in pecans are likely the reason for the previously documented improvements in cardiometabolic health. This study aims to examine the impact of a low dose of pecans on changes in fasting and postprandial lipid metabolism/blood lipids and markers of chronic disease risk. The specific aims of this study are to: * Examine the effect of pecan consumption at a dose of 6% of total energy needs for 12 weeks on fasting and postprandial blood lipids. * Examine the effect of pecan consumption at a dose of 6% of total energy needs for 12 weeks on other markers of chronic disease risk. Participants will be asked to: * Consume pecans daily for 12 weeks or maintain their current habitual diet. * Attend two short visits at 4 and 8 weeks for fasting blood draws, body measurements, and to collect their next 4 weeks' supply of study materials. * Attend two longer (5 h) testing visits, which include eating a standard breakfast meal and having …

This description comes directly from the study's public registry record.

Talk to the study team

Jamie A Cooper, PhD  ·  706-542-4378  ·  jamie.cooper@uga.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of GeorgiaAthens, Georgia, United States

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →